L & S Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-19,361
Closed -$1.75M 313
2020
Q1
$1.75M Buy
19,361
+3,333
+21% +$355K 0.33% 72
2019
Q4
$1.82M Buy
16,028
+4,397
+38% +$482K 0.23% 98
2019
Q3
$1.26M Buy
+11,631
New +$1.21M 0.18% 149
2017
Q3
Sell
-69,889
Closed -$6.2M 302
2017
Q2
$6.2M Sell
69,889
-2,085
-3% -$176K 1.09% 21
2017
Q1
$5.8M Buy
+71,974
New +$5.62M 1.11% 24
2016
Q4
Sell
-57,380
Closed -$4.96M 177
2016
Q3
$4.96M Sell
57,380
-35,896
-38% -$3.13M 1.37% 26
2016
Q2
$8.09M Buy
+93,276
New +$7.54M 1.84% 10
2016
Q1
Sell
-46,049
Closed -$3.54M 92
2015
Q4
$3.54M Buy
46,049
+4,645
+11% +$350K 0.89% 47
2015
Q3
$2.77M Buy
+41,404
New +$3.05M 0.81% 55

Other funds holding MDT

L & S Advisors's MDT Position: Q2 2020 in Review

L & S Advisors sold out of Medtronic (MDT) in Q2 2020, closing a stake of 19,361 shares — an estimated $1.75M sold.

L & S Advisors first reported a position in MDT in Q3 2015 and held it in 9 quarters. The position peaked at $8.09M in Q2 2016. 1,759 funds tracked by Wall St. Rank hold MDT as of Q2 2020.

  • L & S Advisors reported no remaining Medtronic position as of Q2 2020 after selling out during the quarter.
  • L & S Advisors sold 19,361 Medtronic shares in Q2 2020, an estimated $1.75M.
  • L & S Advisors first reported a position in Medtronic in Q3 2015 and held it in 9 quarters.
  • L & S Advisors's Medtronic position peaked at $8.09M in Q2 2016.
  • 1,759 funds tracked by Wall St. Rank held Medtronic as of Q2 2020.

Based on L & S Advisors's 13F filing for Q2 2020, filed 13 Aug 2020.